Prostate cancer

Open Access
Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p
ELENA K. NOHL, JASMIN BEHRING, ERSEN KAMERI, BARBARA KÖDITZ, TIM NESTLER, AXEL HEIDENREICH and MELANIE VON BRANDENSTEIN

Anticancer Research June 2023, 43 (6) 2407-2416; DOI: https://doi.org/10.21873/anticanres.16408
Open Access
Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells
TAKAFUMI SHIMADA, RENATO NAITO, REN TORIUMI, RYUNOSUKE NAKAGAWA, SHUHEI AOYAMA, TAIKI KAMIJIMA, HIROSHI KANO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, KOUJI IZUMI, YOSHIFUMI KADONO, HIROKI NAKATA, YOHEI SAITO, KYOKO NAKAGAWA-GOTO and ATSUSHI MIZOKAMI

Anticancer Research June 2023, 43 (6) 2433-2444; DOI: https://doi.org/10.21873/anticanres.16411
You have access
The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells
ARIUNBOLD NATSAGDORJ, KOUJI IZUMI, KAORU HIRATSUKA, RENATO NAITO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, KAZUYOSHI SHIGEHARA, HIROKI NAKATA and ATSUSHI MIZOKAMI

Anticancer Research June 2023, 43 (6) 2561-2569; DOI: https://doi.org/10.21873/anticanres.16423
Open Access
Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery
YOSUKE TAKAKUSAGI, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, TADASHI KAMADA and HIROYUKI KATOH

Anticancer Research June 2023, 43 (6) 2691-2695; DOI: https://doi.org/10.21873/anticanres.16435
You have access
In Vivo Dosimetry in the Urethra During Prostate Carbon Ion Radiotherapy
SHINNOSUKE MATSUMOTO, NARUHIRO MATSUFUJI, YUSUKE KOBA and HIROSHI TSUJI

Anticancer Research May 2023, 43 (5) 2259-2264; DOI: https://doi.org/10.21873/anticanres.16389
Open Access
Reinforcement of the Tumor Suppressing Properties of microRNA-1 by Substitution at the C2′ Position of Varying Ribose Residues in Chemically Synthesized microRNA-1 Molecules
HANNES AHREND, BETTINA APPEL, LISA JUNG, SABINE MÜLLER and MATTHIAS B. STOPE

Anticancer Research May 2023, 43 (5) 1909-1918; DOI: https://doi.org/10.21873/anticanres.16350
Open Access
Prevalence and Risk Factors of Emotional Distress in Patients With Prostate Cancer Assigned to External-beam Radiotherapy With or Without High-dose Rate Brachytherapy
AHMED AL-SALOOL, TAMER SOROR, NATHAN Y. YU and DIRK RADES

Anticancer Research May 2023, 43 (5) 2103-2109; DOI: https://doi.org/10.21873/anticanres.16371
You have access
Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial
KEIICHIRO MIYAJIMA, TAKAFUMI YANAGISAWA, HIROTAKA SUZUKI, WATARU FUKUOKAYA, KEIGO SAKANAKA, KOKI OBAYASHI, JUN MIKI and TAKAHIRO KIMURA

Anticancer Research April 2023, 43 (4) 1611-1621; DOI: https://doi.org/10.21873/anticanres.16311
You have access
Optimization of Fluence Map for CyberKnife Raster Scanning Intensity Modulated Radiotherapy
YUICHI AKINO, HIROYA SHIOMI, NOBUHISA MABUCHI, NORIHISA MASAI, RYOONG-JIN OH and KAZUHIKO OGAWA

Anticancer Research April 2023, 43 (4) 1637-1642; DOI: https://doi.org/10.21873/anticanres.16314
You have access
Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP and OTAKAR CAPOUN

Anticancer Research April 2023, 43 (4) 1675-1680; DOI: https://doi.org/10.21873/anticanres.16319

Main menu

User menu

Search

Prostate cancer

Pages